Tag: s

Computer Age Management Services Limited

CAMS – India’s Largest RTA – lists on NSE

Chennai, May 8, 2021: Chennai based Computer Age Management Services (CAMS), India’s largest registrar and transfer agent of mutual funds, commenced trading on NSE at Rs 2219.50 per share and closed at Rs 2210 per share. The total quantity traded was 95184 shares with a total delivery percentage of 37%. The Market Capitalization of the company post-closing price stood at Rs 10790 Crores.

As per the Share Holding Pattern filed with NSE as on 30th April 2021 the promoters hold 30.96% in the company and 47.90% is held by Institutions (including Mutual Funds, Foreign Portfolio Investors and Financial Institutions). In the Mutual fund category SBI Mutual Fund, ICICI Prudential, Aditya Birla and HDFC Mutual fund are amongst the top holders. The list of Foreign Portfolio investors includes Small Cap World Fund, Fidelity, and Goldman Sachs.

Speaking on the occasion, Mr. Anuj Kumar, CEO & Whole-time Director, CAMS, said “The company commenced its public listing journey with listing of its shares on the Bombay Stock Exchange on Oct 1st, 2020. NSE investments was a shareholder in CAMS prior to the IPO, and while they exited the company completely during the IPO this shareholding precluded the listing of the company’s shares on NSE at that time. Listing on NSE is a significant milestone for the company and it will help in broad basing our investor base. We are happy to get the approval to list on NSE and gain access to their vast base of retail investors across India”.

Additionally, Mr. Kumar stated “We continue to remain focussed on expanding our business as a technology driven business services provider. We are participating in new and emerging financial infrastructure & platform opportunities. Our recent appointment as the Central Record-keeping Agency for National Pension System (under Pension Fund Regulatory Authority of India), our subsidiary being awarded a license as an Account Aggregator by RBI and our recent application for payment aggregator licence vindicate this focus.

The Board Meeting for taking on record the financials for the year ended 31st March 2021 and for consideration of Final Dividend has been scheduled for 25th May 2021.

Healthium Medtech announces the launch India’s 1st knotless tissue closure device with a triangular end stopper:- “TRUBARB™”

Bangalore: Healthium Medtech, one of the largest medical devices companies in India, today announced the launch of its latest innovation Trubarb™ – a knotless tissue closure device designed to redefine the suturing experience for surgeons. The device comes with barbs and an effective triangular end stopper that eliminates the need for knotting when compared to a regular suture and eliminates the difficulties of looping when compared to other knotless sutures. It has been designed to shorten suturing time, decrease morbidity and ischemic necrosis that arise due to knotting and simplify the overall suturing experience for surgeons.

Sutures are amongst the most used products during surgeries, however, the only significant advances on sutures have been sterilization in 1870ies and synthetic absorbable sutures in 1960ies. By eliminating the need for knotting which is considered a necessary evil in suturing as it reduces the tensile strength of the suture by thinning it, creating a weak spot and building uneven tension across the wound, and by eliminating the unmet needs of wound dehiscence, knot slippage, ischemic necrosis due to knotting and increase in blood loss and morbidity especially in Laparascopic surgeries, Trubarb is looking to redefine the wound closure experience for surgeons.

Speaking on the launch, Anish Bafna, CEO, Healthium Group, said, “As a large Indian player in a market dominated by MNCs, we are trying to innovate constantly to not only drive efficiencies, safety and simplicity for surgeons but also enhance patient safety and outcome. We hold 55 patents in India and the U.S and Trushield™, India’s 1st anti-microbial gloves, Surestitch™, the 1st meniscal repair device designed and manufactured in India, and now Trubarb™ with a Triangular end stopper for the 1st time vs a conventional loop , are all products we have launched this year to serve our customers and provide them with yet another reason to choose an Indian brand! In addition, our products are made to global standards with US FDA and C.E approvals, can be accessed in all 500 districts in India with medical facilities and are accepted in 70 countries. It gives us immense pleasure to launch Trubarb™ so that surgeons can have a secure, swift and simplified suturing experience. “

Dr. Ashok Moharana, Chief Medical Officer, Healthium Medtech said “Healthium is pleased to launch Trubarb™ with the triangular end stopper for the 1st time In India. The triangular end stopper in the Trubarb unidirectional knotless tissue closure device, avoids the looping requirement as compared to other unidirectional barbed sutures with a loop, thus reducing the operation time for surgeons and easing the whole experience. The stopper also enables the device to stand perpendicular to the tissue during the surgery thus preventing the suture spillage and providing the added security. Single angle cut unidirectional helical barbs aid firm fixation and ensure uniform tension over the wound reducing tissue ischemia and necrosis as compared to regular sutures. The needle is made from 300 series steel for easy penetration and is coated with silicone and has a longer taper ratio that offers extra speed during surgery. We hope that Trubarb™ provides an elevated suturing experience for both segments of surgeons, those using ordinary sutures as well as those who use knotless sutures.”

The device has multiple applications and can be used for procedures such as gynaecological, general surgery procedures, urology, oncology and plastic & cosmetic surgeries.

About Healthium Medtech:

The Healthium Group is a conglomerate consisting of Healthium Medtech Pvt. Ltd., one of the largest players in the Indian Medical Devices Market, QNPL, the largest independent manufacturer of Surgical suture needles worldwide by volume, and Clinisupplies a leading player in Urology Consumables in the United Kingdom. The Healthium Group has a lineage of 36 years in creating precision based medical devices across the world. With a vision to create access to Precision MedTech for every patient globally, Healthium MedTech is present in over 70 countries, covers 18000+ hospitals across India and has a workforce of 1500 employees of which 60% are women. Its portfolio includes minimally invasive solutions like Arthroscopy and Endoscopy implants and Ancillary devices, a full range of Absorbable, Non- Absorbable and specialty surgical sutures, wound closure products that include Meshes, Skin staplers, Cardiac Pacing wires and Haemostats. Healthium has 6 Manufacturing facilities across India and the UAE and the Company holds over 55 patents in India and the U.S, including those applied for. Backed by stringent R & D norms, the Company’s products adhere to the highest global quality standards, having accreditations and approvals from 510k (USFDA), CE & ISO.